Monday - Friday - 7:30am - 6:00pm   /   Lunes - Viernes - 7:30am - 6:00pm

State of the Art Technology

Phase 1 UnitFundación de Investigación is a first rate research site with state-of-the-art facilities and medical care clinics with access to a viable patient population for research trials. We have a database of normal volunteers and the capability to conduct all kinds of early studies in both normal volunteers and patients. Our phase I unit’s experienced staff and facilities allow the trials to be conducted without interruption 7 days a week. Our site's advanced technology includes a phase I unit and an in-house bio-analytical laboratory.

Our 30-bed Phase I Unit is the only one in the Caribbean and one of the few in South America. Our phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials. From recruitment through final reporting, we use;

  • Logos Technologies’ ALPHADAS EDC software,
  • Mortara 12-lead wireless telemetry instruments and
    Surveyor™ Telemetry Central system
  • WebDMEMR as our electronic medical record provider.

Fundacion Bioanalytical Laboratory (FBL) is a unit of Fundacion de Investigacion de Puerto Rico that specialize in qualitative and quantitative analysis of chemical and biological pharmaceutical compounds. We provide added value to our customers by advising on the scientific and regulatory situations that could arise in the development of these compounds.

We are a one-stop facility where customers can perform Phase 1 and Phase 2 studies in the same facilities including the pharmacokinetics and pharmacodynamics assessment. This strategy provides faster results for companies decision making processfor the development of their products.

Fundación de Investigación has conducted trials with confinement duration of up to 16 days, including multiple intensive pharmacokinetic and pharmacodynamic trials as SAD and MAD for many molecules. We also conduct hepatic impairment and drug-to-drug interaction studies. We provide to our customers not only scientific but also clinical expertise in the development of pharmaceutical products. Our scientists have extensive experience in the development and validation of bioanalytical methods in the determination of small molecules and their metabolites.

Our reputation as a top clinical trial enroller, our emphasis on quality, plus our extensive experience in research and development, make us the best choice for your clinical trial. We deliver results for you, faster and better.

Logos Tech Mortara WebDMEMR

a database of normal volunteers and the capability to conduct all kinds of early studies in both normal volunteers and patients. Our phase I unit’s experienced staff and facilities allow the trials to be conducted without interruption 7 days a week. Our site's advanced technology includes a phase I unit and an in-house bio-analytical laboratory.

Our 30-bed Phase I Unit is the only one in the Caribbean and one of the few in South America. Our phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials. From recruitment through final reporting, we use;

  • Logos Technologies’ ALPHADAS EDC software,
  • Mortara 12-lead wireless telemetry instruments and
    Surveyor™ Telemetry Central system
  • WebDMEMR as our electronic medical record provider.

Fundacion Bioanalytical Laboratory (FBL) is a unit of Fundacion de Investigacion de Puerto Rico that specialize in qualitative and quantitative analysis of chemical and biological pharmaceutical compounds. We provide added value to our customers by advising on the scientific and regulatory situations that could arise in the development of these compounds.

We are a one-stop facility where customers can perform Phase 1 and Phase 2 studies in the same facilities including the pharmacokinetics and pharmacodynamics assessment. This strategy provides faster results for companies decision making processfor the development of their products.

Fundación de Investigación has conducted trials with confinement duration of up to 16 days, including multiple intensive pharmacokinetic and pharmacodynamic trials as SAD and MAD for many molecules. We also conduct hepatic impairment and drug-to-drug interaction studies. We provide to our customers not only scientific but also clinical expertise in the development of pharmaceutical products. Our scientists have extensive experience in the development and validation of bioanalytical methods in the determination of small molecules and their metabolites.

Our reputation as a top clinical trial enroller, our emphasis on quality, plus our extensive experience in research and development, make us the best choice for your clinical trial. We deliver results for you, faster and better.

Logos Tech Mortara WebDMEMR

Who We Are?

Located in San Juan, Puerto Rico, Fundación de Investigación (FDI) is a clinical research center with state-of-the-art facilities that comprise medical treatment for multiple conditions, a 30-bed phase I unit, an in-house bioanalytical laboratory, multispecialty experienced personnel, and the latest in medical technology. We are also an active medical care facility for patients with diverse medical ailments.

Executive Leadership

Dr. Jose F. Rodriguez-Orengo
Chief Executive Offcicer - CEO,
Chief Scientific Officer & BioLab Director


Grisell Ortíz-Lasanta, MD
Associate Director

Mirelis Acosta, MD
Chief Medical Officer

Michelle Echeandia
Chief Operating Officer

Our partners

Gilead Pharmaceuticals
Amgen
Astra Zeneca
Bristol Myers Squibb
GlaxoSmithKline
Merck Sharp
Novartis Pharmaceuticals
Pfizer
Sanofi-aventis
Jansen Pharmaceuticals

Where to find us?

Address
Fundación de Investigación
998 Muñoz Rivera Ave.
San Juan, PR 00927

Phone Number
Tel. (787) 722-1248
Fax. (787) 721-6098